针对A35的人类单克隆抗体可以预防mopox引起的死亡
Raianna F Fantin1, Meng Yuan2, Seok-Chan Park3
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Cell
|August 27, 2025
概括
研究人员发现了三种针对病毒 (MPXV) A35蛋白的人类单克隆抗体 (mAbs). 这些mAbs显示为治疗脊髓炎病毒感染的前景, 提供潜在的新疗法.
科学领域:
- 病毒学
- 免疫学
- 治疗药物
背景情况:
- 2022年麻疹疫情强调了对有效麻疹病毒 (MPXV) 治疗的迫切需要.
- 目前对MPXV感染的治疗选择有限,这对公众健康构成重大挑战.
研究的目的:
- 识别和描述针对MPXV的新型人类单克隆抗体 (mAbs).
- 评估这些mAbs对骨病毒感染的治疗潜力.
主要方法:
- 从mpox康复的个体中分离出高亲和度的人类mAbs.
- 在体外评估抗体介导的病毒扩散抑制.
- 在使用致命的MPXV和疫苗病毒挑战的小鼠模型中进行了体内疗效研究.
- 血清抗体水平的分析及其与mopox患者的临床结果的相关性
主要成果:
- 发现了针对MPXV A35蛋白的三种mAbs (EV35-2,EV35-6,EV35-7).
- 这些mAbs在试验室中有效阻止病毒传播,并保护小鼠免受致命的脊髓炎病毒感染.
- 在康复期患者中,针对类似表位体的较高血清抗体水平与较轻的疾病和减少住院相关.
- 在两个mAbs中保存的基因使结合到高度保存的天花病毒表位素变得容易.
结论:
- A35蛋白是针对MPXV治疗的关键点.
- A35 特定的 mAbs 是下一代脊髓炎病毒治疗的有希望的候选者.
- 针对特定表位体的抗体的合作和添加作用可能有助于临床保护.
相关概念视频
Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K
Antibody Actions
1.3K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.3K


